Abstract | BACKGROUND: The Japanese guidelines for the treatment of alopecia areata list topical immunotherapies as a drug therapy for this condition. However, there is insufficient evidence of its efficacy to support this recommendation. Thus, we sought to clarify the effect of topical immunotherapy on the progression and severity of alopecia areata in Japanese patients. METHODS: RESULTS: The improvement rate in all alopecia patients treated with SADBE topical immunotherapy was 57.8% (complete response; 11.1% and partial response; 46.7%). CONCLUSIONS:
|
Authors | Keisuke Sakai, Satoshi Fukushima, Satoru Mizuhashi, Masatoshi Jinnin, Takamitsu Makino, Yuji Inoue, Hironobu Ihn |
Journal | Allergology international : official journal of the Japanese Society of Allergology
(Allergol Int)
Vol. 69
Issue 2
Pg. 274-278
(Apr 2020)
ISSN: 1440-1592 [Electronic] England |
PMID | 31767273
(Publication Type: Journal Article)
|
Copyright | Copyright © 2019 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved. |
Chemical References |
- Cyclobutanes
- squaric acid diethyl ester
|
Topics |
- Administration, Topical
- Adolescent
- Alopecia
- Alopecia Areata
(drug therapy)
- Cohort Studies
- Cyclobutanes
(therapeutic use)
- Female
- Follow-Up Studies
- Humans
- Immunotherapy
(methods)
- Japan
- Male
- Retrospective Studies
- Severity of Illness Index
- Treatment Outcome
|